(CODEL): Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Eligible for screening study DCP 001
N0577 is closed to accrual to pre-registration (Step 0), effective May 24, 2024, at 4:00 pm ET.
N0577 is closed to accrual to registration (Step 1), effective June 10, 2024, at 4:00 pm ET.
